ANXA1 and glomerular disorder: ANXA1 became detectable in the urine as early as day 7 in the ADG model (Figure 5) and, importantly, was detectable in almost all urine samples from patients with glomerular disorders except those with MCD (less than 10.52% of cases were detected).